Status:
COMPLETED
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
Lead Sponsor:
NICHD Neonatal Research Network
Collaborating Sponsors:
National Center for Research Resources (NCRR)
Conditions:
Infant, Newborn
Infant, Low Birth Weight
Eligibility:
All Genders
Up to 14 years
Brief Summary
This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generi...
Detailed Description
Retrospective studies suggested that the risk of cerebral palsy and intraventricular hemorrhage (IVH) in extremely premature infants of mothers given magnesium sulfate (MgSO4) may be reduced. The purp...
Eligibility Criteria
Inclusion
- Infants born in NRN Centers with a birth weight of 401-1,500g
Exclusion
- None
Key Trial Info
Start Date :
July 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2000
Estimated Enrollment :
1339 Patients enrolled
Trial Details
Trial ID
NCT01203501
Start Date
July 1 1996
End Date
June 1 2000
Last Update
September 26 2017
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
2
Stanford University
Palo Alto, California, United States, 94304
3
Yale University
New Haven, Connecticut, United States, 06504
4
George Washington University
Washington D.C., District of Columbia, United States, 20052